Copyright
©The Author(s) 2020.
World J Gastroenterol. Nov 21, 2020; 26(43): 6853-6866
Published online Nov 21, 2020. doi: 10.3748/wjg.v26.i43.6853
Published online Nov 21, 2020. doi: 10.3748/wjg.v26.i43.6853
Figure 2 Correlation between doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 immuno-histochemical expression in colorectal cancer specimens.
Doublecortin-like kinase 1 (DCLK1) and leucine-rich repeat-containing G-protein-coupled receptor 5 expression were positively significantly correlated (r = 0.206, P < 0.001). DCLK1: Doublecortin-like kinase 1; Lgr5: Leucine-rich repeat-containing G-protein-coupled receptor 5.
- Citation: Kang XL, He LR, Chen YL, Wang SB. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis. World J Gastroenterol 2020; 26(43): 6853-6866
- URL: https://www.wjgnet.com/1007-9327/full/v26/i43/6853.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i43.6853